Y-mAbs Therapeutics, Inc. Annual Operating Lease, Payments in USD from 2019 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
Y-mAbs Therapeutics, Inc. quarterly/annual Operating Lease, Payments history and growth rate from 2019 to 2023.
  • Y-mAbs Therapeutics, Inc. Operating Lease, Payments for the quarter ending September 30, 2024 was $247K, a 7.14% decline year-over-year.
  • Y-mAbs Therapeutics, Inc. Operating Lease, Payments for the twelve months ending September 30, 2024 was $1.01M, a 27.3% decline year-over-year.
  • Y-mAbs Therapeutics, Inc. annual Operating Lease, Payments for 2023 was $1.06M, a 53.8% decline from 2022.
  • Y-mAbs Therapeutics, Inc. annual Operating Lease, Payments for 2022 was $2.29M, a 3.16% increase from 2021.
  • Y-mAbs Therapeutics, Inc. annual Operating Lease, Payments for 2021 was $2.22M, a 77.6% increase from 2020.
Operating Lease, Payments, Trailing 12 Months (USD)
Operating Lease, Payments, Annual (USD)
Operating Lease, Payments, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $1.06M -$1.23M -53.8% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-29
2022 $2.29M +$70K +3.16% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-29
2021 $2.22M +$968K +77.6% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-30
2020 $1.25M +$642K +106% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-01
2019 $606K Jan 1, 2019 Dec 31, 2019 10-K 2022-03-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.